Published in Drug Week, February 10th, 2006
Four companies - Chembio (U.S.), Orgenics (Israel; a subsidiary of Inverness Medical Innovations), Qualpro Diagnostics (India), and Shanghai Kehua (China) - will offer rapid tests for US$0.49-$0.65 per test. As a result of their agreements with the Clinton Foundation, countries will be able to reduce the cost of HIV diagnosis by 50%.
Cipla (India), Ranbaxy (India), Strides Arcolab (India), and Aspen Pharmacare (South Africa), relying on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.